The organization has voted in favor of a resolution urging FDA to meet its proposed goal within ten years.
The American Public Health Association (APHA; Washington, DC) is calling for a reduction of sodium in the U.S. food supply by 75%, according to reports from the Center for Science in the Public Interest (CSPI; Washington, DC).
CSPI reports that, at APHAs’ 139th annual meeting, AHPA voted in favor of a resolution urging FDA to meet its proposed goal within ten years. The resolution also asks FDA to “remove or modify” salt’s current GRAS status, which allows the ingredient to avoid a maximum level in prepared foods.
AHPA’s resolution also supports a daily recommendation of sodium intake at no more than 1500 mg per day-a figure that was endorsed by the American Heart Association in 2010.
“According to the government’s dietary advice, only people with hypertension, people who are middle-aged and older, and African Americans should consume no more than 1500 mg of sodium daily,” said CSPI in a press release. “People in those groups represent about 70% of adults. The rest should consume no more than 2300 mg of sodium per day, about a teaspoon of salt. However, Americans are consuming close to 4000 mg of sodium per day-an amount that ‘far exceeds current recommendations and physiologic need,’ according to the APHA resolution.”
FDA was reportedly scheduled to hold a public meeting on sodium on November 10.
The APHA resolution on salt reduction can be downloaded here.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.
Recent review makes the case for testing omega-3 fatty acid levels in humans
May 23rd 2024The article commissioned by The Global Organization for EPA and DHA Omega-3s (GOED) reviewed the state of omega-3 fatty acid testing, highlighting the value of testing and the commercially available options for diagnostic testing.
Epax launches concentrated oil that combines omegas 3, 9, and 11
May 10th 2024The blend of long-chain polyunsaturated fatty acids and long-chain monounsaturated fatty acids combines the heart and brain health benefits of omegas-3s with the skin and metabolic health benefits of omegas 9 and 11.